Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review).

Abstract:

:Hepatocellular carcinoma (HCC) is one of the most common tumors in the world. At present, the details of the mechanism responsible for HCC formation and maintenance remain unclear. However, the cancer stem cell (CSC) theory suggests that liver cancer stem cells (LCSCs) may be responsible for the biological characteristics of HCC. Dysregulation of signaling pathways, including transforming growth factor β (TGF-β), Wnt, Notch and Hedgehog pathways, has been found to be involved in the process of hepatocarcinogenesis and is considered the key determinant of LCSC function. Numerous LCSC biomarkers have been identified including CD133, epithelial cell adhesion molecule (EpCAM), ABCG2 and CD90, which would contribute to the isolation of LCSCs.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Song K,Wu J,Jiang C

doi

10.3892/or.2012.2082

subject

Has Abstract

pub_date

2013-01-01 00:00:00

pages

3-12

issue

1

eissn

1021-335X

issn

1791-2431

journal_volume

29

pub_type

杂志文章,评审
  • Novel EXT1 mutation identified in a pedigree with hereditary multiple exostoses.

    abstract::Hereditary multiple exostoses (HME) is an autosomal dominant bone disorder characterized by the presence of multiple benign cartilage-capped tumors. EXT1 located on chromosome 8q23-q24 and EXT2 located on 11p11-p12 are the main disease-causing genes which are responsible for ~90% of HME cases. Mutations of EXT1 or EXT...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2891

    authors: Cao L,Liu F,Kong M,Fang Y,Gu H,Chen Y,Zhao C,Zhang S,Bi Q

    更新日期:2014-02-01 00:00:00

  • miR‑107‑5p promotes tumor proliferation and invasion by targeting estrogen receptor‑α in endometrial carcinoma.

    abstract::The aberrant expression of miR107‑5p is closely related to the development of several types of human cancers. However, the role of miR‑107‑5p in endometrial carcinoma (EC) has not been fully confirmed. In the present study, we aimed to explore the function of miR‑107‑5p in EC carcinogenesis. EC samples and normal endo...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6936

    authors: Bao W,Zhang Y,Li S,Fan Q,Qiu M,Wang Y,Li Y,Ji X,Yang Y,Sang Z,Xu W,Yang Y,Wu S,Zhu Y

    更新日期:2019-03-01 00:00:00

  • Antitumor effects of IDN5109 on head and neck squamous cell carcinoma.

    abstract::Taxanes, a new class of antitumor drugs, are effective against a large number of human tumors, although there are problems with drug resistance. The novel taxane, IDN5109, is characterized by its high tolerability, antitumor efficacy, ability to overcome multidrug resistance, and oral bioavailabilty. We investigated t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Sano D,Matsuda H,Ishiguro Y,Nishimura G,Kawakami M,Tsukuda M

    更新日期:2006-02-01 00:00:00

  • MicroRNA‑203a‑3p is a candidate tumor suppressor that targets thrombospondin 2 in colorectal carcinoma.

    abstract::The aim of the present study was to investigate the role of miR‑203a‑3p in colorectal cancer (CRC) and identify the target gene of microRNA (miR)‑203a‑3p. A total of 59 sets of cancer tissues and corresponding adjacent non‑tumor tissues were collected from CRC patients (aged 31‑78 years) between October 2016 and May 2...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7310

    authors: Qian Z,Gong L,Mou Y,Han Y,Zheng S

    更新日期:2019-11-01 00:00:00

  • Downregulation of occludin affects the proliferation, apoptosis and metastatic properties of human lung carcinoma.

    abstract::Lung cancer is the most frequent and deadliest cancer in the world, especially in China. However, the molecular mechanisms involved in lung cancer remain unclear. Occludin (OCLN), one of the first identified tight junction proteins, has been revealed to be a necessary integral protein for tight junction structure and ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6408

    authors: Wang M,Liu Y,Qian X,Wei N,Tang Y,Yang J

    更新日期:2018-07-01 00:00:00

  • G31P, CXCR1/2 inhibitor, with cisplatin inhibits the growth of mice hepatocellular carcinoma and mitigates high‑dose cisplatin-induced nephrotoxicity.

    abstract::Cisplatin (DDP), a cytotoxic antitumor drug, functions in a dose-dependent manner. However, the pursuit for high‑dose therapeutic effects leads to more serious side effects including kidney toxicity. Nephrotoxicity caused due to endothelial cell dysfunction and neutrophils infiltration in kidneys. Interleukin-8 (IL-8)...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3659

    authors: Li L,Khan MN,Li Q,Chen X,Wei J,Wang B,Cheng JW,Gordon JR,Li F

    更新日期:2015-02-01 00:00:00

  • Knockdown of CXCR7 inhibits proliferation and invasion of osteosarcoma cells through inhibition of the PI3K/Akt and β-arrestin pathways.

    abstract::CXC chemokine receptor 7 (CXCR7) has been implicated in tumor development and metastasis in multiple malignancies. Yet, the function and molecular mechanisms of CXCR7 in human osteosarcoma (OS) are still unclear. The aim of the present study was to investigate the role of CXCR7 in human OS. The expression of CXCR7 was...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3290

    authors: Zhang Y,Yang CQ,Gao Y,Wang C,Zhang CL,Zhou XH

    更新日期:2014-09-01 00:00:00

  • Pancreatic tumor mass in a xenograft mouse model is decreased by treatment with therapeutic stem cells following introduction of therapeutic genes.

    abstract::Pancreatic cancer is the fourth most common cause of cancer-related mortality. In the present study, we employed 2 types of therapeutic stem cells expressing cytosine deaminase (CD) with or without human interferon-β (IFN‑β), HB1.F3.CD and HB1.F3.CD.IFN-β cells, respectively, to selectively treat pancreatic cancer. Th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2564

    authors: Kim DJ,Yi BR,Lee HR,Kim SU,Choi KC

    更新日期:2013-09-01 00:00:00

  • EPHX1 polymorphisms do not modify esophageal carcinoma susceptibility in Dutch Caucasians.

    abstract::Esophageal cancer (EC) has a globally increasing incidence with poor curative treatment options and survival rates. Crucial risk factors are exposure to toxins or carcinogens. Microsomal epoxide hydrolase (mEH) is a biotransformation enzyme essential for the detoxification of xenobiotics. Polymorphisms in exon 3 and e...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1734

    authors: Dura P,Bregitha CV,Te Morsche RH,Roelofs HM,Kristinsson JO,Wobbes T,Witteman BJ,Tan AC,Drenth JP,Peters WH

    更新日期:2012-06-01 00:00:00

  • Livistona chinensis seeds inhibit hepatocellular carcinoma angiogenesis in vivo via suppression of the Notch pathway.

    abstract::Livistona chinensis seeds have been used for centuries to clinically treat various types of cancer. Our published data suggest that Livistona chinensis seeds are able to inhibit hepatocellular carcinoma (HCC) growth in vitro and in vivo via promotion of mitochondrial-dependent apoptosis. To further elucidate the molec...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3051

    authors: Lin W,Zhao J,Cao Z,Zhuang Q,Zheng L,Zeng J,Hong Z,Peng J

    更新日期:2014-04-01 00:00:00

  • Contrasting effects of extended low dose versus standard dose shorter course UFT chemotherapy on microscopic versus macroscopic established tumors: implications for optimal postoperative adjuvant chemotherapy.

    abstract::Given such differences as relative tumor burden, the optimal dose and schedule for postoperative adjuvant chemotherapy of microscopic disease might be expected to differ significantly from therapy of advanced higher volume disease. We investigated this hypothesis by determining the optimal dose and schedule of the 5-F...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Uchida J,Okabe H,Nakano K,Fujioka A,Saito H,Sugimoto Y,Oka T,Fukushima M

    更新日期:2007-08-01 00:00:00

  • Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.

    abstract::Matrix metalloproteinases (MMPs) are associated with invasion and metastasis of several human malignant tumors. Especially so MMP-7, as it is mainly produced by the actual cancer cells. However, the expression of MMP-7 in transitional cell carcinoma (TCC) of the urinary bladder has not been previously investigated. We...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Sumi T,Yoshida H,Hyun Y,Yasui T,Matsumoto Y,Hattori K,Sugimura K,Kawashima H,Nakatani T,Ishiko O

    更新日期:2003-03-01 00:00:00

  • CLDN5 affects lncRNAs acting as ceRNA dynamics contributing to regulating blood‑brain barrier permeability in tumor brain metastasis.

    abstract::The blood‑brain barrier (BBB) constitutes an efficient organization of tight junctions that limits the delivery of tumor to the brain. The principal tight junction protein in BBB is claudin‑5 (CLDN5), but its mechanism of action remains largely unknown. Long non‑coding RNAs (lncRNAs) are aberrantly expressed in many c...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6208

    authors: Ma SC,Li Q,Peng JY,Zhouwen JL,Zhang DN,Zhang CB,Jiang WG,Jia W

    更新日期:2018-03-01 00:00:00

  • Activation of PAR2 or/and TLR4 promotes SW620 cell proliferation and migration via phosphorylation of ERK1/2.

    abstract::Protease-activated receptor 2 (PAR2) is a G-protein-coupled receptor and its activation has been associated with the pathogenetic progress in certain cancers. Toll-like receptor 4 (TLR4), one member of Toll-like receptors family, is mainly contributed to the innate immune response. However, recent studies have shown t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2010.1077

    authors: Zhou B,Zhou H,Ling S,Guo D,Yan Y,Zhou F,Wu Y

    更新日期:2011-02-01 00:00:00

  • Aberrant expression of beta-catenin, Pin1 and cylin D1 in salivary adenoid cystic carcinoma: relation to tumor proliferation and metastasis.

    abstract::The aims of this study were to investigate the expression levels of beta-catenin, Pin1 and cyclin D1 in salivary adenoid cystic carcinomas (SACC ) and to evaluate its clinical importance, furthermore, to elucidate whether beta-catenin expression was aberrant in SACC and whether Pin1 was involved in aberrant beta-caten...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Zhou CX,Gao Y

    更新日期:2006-09-01 00:00:00

  • EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy.

    abstract::The present study explored the correlation of ecotropic viral integration site 5 (EVI5) expression with clinicopathological features and prognosis in hepatocellular carcinoma (HCC). A total of 205 HCC patients were included retrospectively. Quantitative real-time polymerase chain reaction (RT-qPCR) and western blottin...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5862

    authors: Tang J,Ou J,Xu C,Yi C,Xue F,Xu L,Lai F,Tang J,Li S,Kang T,Ding W,Wang B

    更新日期:2017-10-01 00:00:00

  • Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma.

    abstract::Progestin and adipoQ receptor family member III (PAQR3) is a regulator that negatively modulates the Ras/Raf/MEK/ERK signaling cascade and the GPCR Gβγ subunit signaling pathway. The role of PAQR3 in hepatocellular carcinoma (HCC) has not been elucidated. The present study investigated the expression of PAQR3 and its ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3532

    authors: Wu HG,Zhang WJ,Ding Q,Peng G,Zou ZW,Liu T,Cao RB,Fei SJ,Li PC,Yang KY,Hu JL,Dai XF,Wu G,Li PD

    更新日期:2014-12-01 00:00:00

  • Efficacy of the combined use of bevacizumab and irinotecan as a postoperative adjuvant chemotherapy in colon carcinoma.

    abstract::We evaluated the efficacy of anti-human VEGF antibody (bevacizumab) with or without irinotecan (CPT-11) against lung metastases in which neovascularization was already induced, as a postoperative adjuvant therapy using orthotopically implanted colon cancer in rat. The high VEGF productive KM12SM human colon cancer cel...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Mizobe T,Ogata Y,Murakami H,Akagi Y,Ishibashi N,Mori S,Sasatomi T,Shirouzu K

    更新日期:2008-09-01 00:00:00

  • Increased proliferation of middle to distal colonic cells during colorectal carcinogenesis in experimental murine ulcerative colitis.

    abstract::Patients with ulcerative colitis (UC) exhibit an increased risk for the development of cancer of the colon and rectum. This association is widely attributed to colonic inflammation. However, the severity of colonic inflammation necessary for the development of dysplasia and/or cancer remains unknown. In this study, we...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Inoue T,Murano M,Kuramoto T,Ishida K,Kawakami K,Abe Y,Morita E,Murano N,Toshina K,Nishikawa T,Maemura K,Shimamoto C,Hirata I,Katsu K,Higuchi K

    更新日期:2007-12-01 00:00:00

  • [Corrigendum] Lycorine inhibits cell proliferation and migration by inhibiting ROCK1/cofilin‑induced actin dynamics in HepG2 hepatoblastoma cells.

    abstract::After having carefully checked the original data of Fig. 3, the authors noted that the student in their research group had inadvertently selected incorrect images for the 10 and 20 µM lycorine experiments to show the effect of lycorine on the migration of HepG2 cells during the figure compilation process. The correcte...

    journal_title:Oncology reports

    pub_type: 杂志文章,已发布勘误

    doi:10.3892/or.2019.7362

    authors: Liu W,Zhang Q,Tang Q,Hu C,Huang J,Liu Y,Lu Y,Wang Q,Li G,Zhang R

    更新日期:2019-12-01 00:00:00

  • Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer.

    abstract::The aim of this study was to better understand the mechanisms of tumor development and disease progression in human epithelial ovarian cancer. Fifty genes were screened for gene signature; 20 expressed genes were assessed in tumor and normal samples of EOC patients by RT-PCR. Expres...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1483

    authors: Guo Y,Fu P,Zhu H,Reed E,Remick SC,Petros W,Mueller MD,Yu JJ

    更新日期:2012-01-01 00:00:00

  • The inhibition of growth and angiogenesis in heterotransplanted esophageal carcinoma via intratumoral injection of arsenic trioxide.

    abstract::To investigate the antitumor action of arsenic trioxide (As2O3) by intratumoral injection into solid tumors, tumor growth inhibition (TGI) and angiogenesis of heterotransplanted esophageal carcinoma in mice was carried out. The cultured human esophageal carcinoma cells were inoculated into both laterals of the abdomin...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Shen ZY,Shen J,Chen MH,Wu XY,Wu MH,Zeng Y

    更新日期:2003-11-01 00:00:00

  • 3,3'-Diindolylmethane suppresses growth of human esophageal squamous cancer cells by G1 cell cycle arrest.

    abstract::3,3'-Diindolylmethane (DIM), an active metabolite of indole-3-carbinol, is thought to have antitumor effects in experimental animals and induce apoptosis in various cancer cells. However, the biological functions of DIM in human esophageal cancer cells are unknown. Thus, the purpose...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1662

    authors: Kim SJ,Lee JS,Kim SM

    更新日期:2012-05-01 00:00:00

  • Characteristics of PBMC obtained from leukapheresis products and tumor biopsies of patients with non-small cell lung cancer.

    abstract::The current study characterized peripheral blood mononuclear cells (PBMC) obtained from leukapheresis products of patients with non-small cell lung cancer (NSCLC) for cytokine release, the ability to incorporate tritiated thymidine following stimulation using PHA as well as the levels of both CD4 and CD8 regulatory T ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000588

    authors: Yannelli JR,Tucker JA,Hidalgo G,Perkins S,Kryscio R,Hirschowitz EA

    更新日期:2009-12-01 00:00:00

  • Overexpression of IL-9 induced by STAT3 phosphorylation is mediated by miR-155 and miR-21 in chronic lymphocytic leukemia.

    abstract::Interleukin‑9 (IL‑9) can function as both a positive and negative regulator of immune response, however the role of IL‑9 in tumor immunity is poorly understood. Chronic lymphocytic leukemia (CLL) is the most common chronic lympho‑proliferative disorder. Twenty CLL patients from 2010 to 2011 were recruited in the study...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6367

    authors: Chen N,Feng L,Qu H,Lu K,Li P,Lv X,Wang X

    更新日期:2018-06-01 00:00:00

  • In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer.

    abstract::The development and characterization of effective anticancer drugs against colorectal cancer (CRC) is of urgent need since it is the second most common cause of cancer death. The study was designed to evaluate the effects of two IGF-1R antagonists, MK-0646, a recombinant fully humanized monoclonal antibody and OSI-906...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2819

    authors: Leiphrakpam PD,Agarwal E,Mathiesen M,Haferbier KL,Brattain MG,Chowdhury S

    更新日期:2014-01-01 00:00:00

  • A single nucleotide polymorphism in fibronectin 1 determines tumor shape in colorectal cancer.

    abstract::Depressed and flat surface lesions are not easy to identify with routine colonoscopies during screening for colorectal cancer (CRC). Identifying clinically relevant genes that influence tumor shape could be useful when screening for the presence of depressed lesions. Total RNA was extracted from tumor cells collected ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3251

    authors: Kida H,Takano Y,Yamamoto K,Mori M,Yanaga K,Tanaka J,Kudo SE,Mimori K

    更新日期:2014-08-01 00:00:00

  • miR520c blocks EMT progression of human breast cancer cells by repressing STAT3.

    abstract::Breast cancer is one of the most malignant diseases world-wide and it ranks the first among female cancers. Masses of intrinsic and extrinsic factors, especially the inflammatory factors can lead to breast cancer. Aberrant activation and accumulation of key molecules can lead to inflammation associated carcinogenesis....

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5393

    authors: Wang N,Wei L,Huang Y,Wu Y,Su M,Pang X,Wang N,Ji F,Zhong C,Chen T,Li B

    更新日期:2017-03-01 00:00:00

  • Antibody therapies for melanoma: new and emerging opportunities to activate immunity (Review).

    abstract::The interface between malignant melanoma and patient immunity has long been recognised and efforts to treat this most lethal form of skin cancer by activating immune responses with cytokine, vaccine and also antibody immunotherapies have demonstrated promise in limited subsets of patients. In the present study, we dis...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or.2014.3275

    authors: Malas S,Harrasser M,Lacy KE,Karagiannis SN

    更新日期:2014-09-01 00:00:00

  • Antitumor effect of gefitinib on head and neck squamous cell carcinoma enhanced by trastuzumab.

    abstract::The overexpression of EGFR and/or HER-2 is associated with tumor cell resistance to chemotherapy, radiotherapy, disease progression and poor prognosis in patients with a variety of malignant tumors. Treatment combining the EGFR-targeting drug, gefitinib (ZD1839, Iressa) with the HER-2-targeting drug, trastuzumab (Herc...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Kondo N,Ishiguro Y,Kimura M,Sano D,Fujita K,Sakakibara A,Taguchi T,Toth G,Matsuda H,Tsukuda M

    更新日期:2008-08-01 00:00:00